Format

Send to

Choose Destination
J Clin Endocrinol Metab. 2018 Aug 1;103(8):2761-2784. doi: 10.1210/jc.2018-01175.

Hypothalamic-Pituitary and Growth Disorders in Survivors of Childhood Cancer: An Endocrine Society Clinical Practice Guideline.

Author information

1
Memorial Sloan-Kettering Cancer Center, New York, New York.
2
Weill Cornell Medicine and New York Presbyterian Hospital, New York, New York.
3
St. Jude Children's Research Hospital, Memphis, Tennessee.
4
Boston Children's Hospital, Boston, Massachusetts.
5
Skåne University Hospital, Lund, Sweden.
6
Emory University School of Medicine, Atlanta, Georgia.
7
Mayo Clinic Evidence-Based Practice Center, Rochester, Minnesota.

Abstract

Objective:

To formulate clinical practice guidelines for the endocrine treatment of hypothalamic-pituitary and growth disorders in survivors of childhood cancer.

Participants:

An Endocrine Society-appointed guideline writing committee of six medical experts and a methodologist.

Conclusions:

Due to remarkable improvements in childhood cancer treatment and supportive care during the past several decades, 5-year survival rates for childhood cancer currently are >80%. However, by virtue of their disease and its treatments, childhood cancer survivors are at increased risk for a wide range of serious health conditions, including disorders of the endocrine system. Recent data indicate that 40% to 50% of survivors will develop an endocrine disorder during their lifetime. Risk factors for endocrine complications include both host (e.g., age, sex) and treatment factors (e.g., radiation). Radiation exposure to key endocrine organs (e.g., hypothalamus, pituitary, thyroid, and gonads) places cancer survivors at the highest risk of developing an endocrine abnormality over time; these endocrinopathies can develop decades following cancer treatment, underscoring the importance of lifelong surveillance. The following guideline addresses the diagnosis and treatment of hypothalamic-pituitary and growth disorders commonly encountered in childhood cancer survivors.

PMID:
29982476
DOI:
10.1210/jc.2018-01175

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center